- ►icirculation.com [PDF] MS Sabatine, CP Cannon, CM Gibson, JL … - New England Journal …, 2005 - content.nejm.org Methods We enrolled 3491 patients, 18 to 75 years of age, who presented within 12 hours after
the onset of an ST-elevation myocardial infarction and randomly assigned them to receive clopidogrel
(300-mg loading dose, followed by 75 mg once daily) or placebo. Patients received a ... Cited by 657 - Related articles - All 23 versions
MS Sabatine, CP Cannon, CM Gibson, JL Lopez- … - Jama, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context The benefit of clopidogrel pretreatment ... Cited by 258 - Related articles - BL Direct - All 9 versions
- ►oxfordjournals.org M Moscucci, KAA Fox, CP Cannon, W Klein, … - European Heart …, 2003 - Eur Soc Cardiology Methods and results Data from 24 045 patients from the Global Registry of Acute Coronary Events
(GRACE) were analysed. Factors associated with major bleeding were identified using logistic
regression analysis. Predictive models were developed for the overall patient population ... Cited by 249 - Related articles - All 7 versions
EM Antman, HW Louwerenburg, HF Baars, JCL … - Circulation, 2002 - Am Heart Assoc Methods and Results— Patients (n=483) with ST-elevation MI presenting <6 hours from symptom
onset were randomized to full-dose TNK and either unfractionated heparin (UFH) (bolus 60
U/kg; infusion 12 U/kg per hour) or enoxaparin (1.0 mg/kg subcutaneously every 12 ... Cited by 225 - Related articles - BL Direct - All 8 versions
- ►ahajournals.org PA Gurbel, KP Bliden, KA Zaman, JA Yoho, KM Hayes, … - Circulation, 2005 - Am Heart Assoc Methods and Results— Patients undergoing elective stenting (n=120) were enrolled in a 2x2
factorial study (300 mg clopidogrel with or without eptifibatide; 600 mg clopidogrel with or without
eptifibatide) (Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets [ ... Cited by 218 - Related articles - All 8 versions
BA Keyt, NF Paoni, CJ Refino, L Berleau, … - … OF SCIENCES USA, 1994 - National Acad Sciences BRUCE A. KEYT*, NICHOLAS F. PAONI*, CANIO J. REFINO*, LEA BERLEAU*, HUNG
NGUYEN*, ALICE CHOW*, JADINE LAI*, LUIS PENA*, CHERYL PATER*, JOHN OGEZt, TINA
ETCHEVERRYt, DAVID BOTSTEIN§ķ, AND WILLIAM F. BENNETrt Cited by 198 - Related articles - BL Direct - All 10 versions
- ►ahajournals.org SD Wiviott, EM Antman, KJ Winters, G Weerakkody, SA … - Circulation, 2005 - Am Heart Assoc Methods and Results— Joint Utilization of Medications to Block Platelets Optimally–Thrombolysis
In Myocardial Infarction 26 (JUMBO-TIMI 26) was a phase 2, randomized, dose-ranging,
double-blind safety trial of prasugrel versus clopidogrel in 904 patients undergoing ... Cited by 174 - Related articles - All 9 versions
- ►ahajournals.org JL Anderson, BD Horne, SM Stevens, AS Grove, S … - Circulation, 2007 - Am Heart Assoc Methods and Results— Consenting patients (n=206) being initiated on warfarin were randomized
to pharmacogenetic-guided or standard dosing. Buccal swab DNA was genotyped for CYP2C9
*2 and CYP2C9 *3 and VKORC1C1173T with a rapid assay. Standard dosing followed ... Cited by 148 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org DP Lee, NA Herity, BL Hiatt, WF Fearon, M Rezaee, AJ … - Circulation, 2003 - Am Heart Assoc Methods and Results— A total of 100 patients presenting with acute myocardial infarction were
randomized to either early administration of tirofiban in the emergency room or later administration
in the catheterization laboratory. The primary outcome measures were initial TIMI grade ... Cited by 149 - Related articles - BL Direct - All 10 versions
MA Blazing, JA de Lemos, HD White, KAA Fox, FWA … - Jama, 2004 - Am Med Assoc Context Enoxaparin or the combination of glycoprotein IIb/IIIa inhibitor tirofiban with unfractionated
heparin independently have shown superior efficacy over unfractionated heparin alone in patients
with non–ST-elevation acute coronary syndromes (ACS). It is not clear if combining ... Cited by 135 - Related articles - BL Direct - All 10 versions
